Under a new program, eligible Medicare enrollees may purchase certain GLP-1 weight loss drugs for $50 per month, expanding ...
Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month.
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with some downsides takes its place.
Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the popular weight-loss drugs ...
The GLP‑1 Bridge pilot program would allow Medicare to broadly cover weight‑loss versions of GLP‑1 medications, such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results